Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain

SS Bowersox, T Gadbois, T Singh, M Pettus, YX Wang and RR Luther

Department of Pharmacology, Neurex Corporation, Menlo Park, California, USA.

Male Sprague-Dawley rats were used to evaluate the antinociceptive properties of the selective N-type voltage-sensitive calcium channel (VSCC) blocker, SNX-111, when the compound is administered spinally by either bolus injection or continuous, constant-rate infusion into the subarachnoid space. SNX-111 produced significant, dose-dependent antinociceptive effects by suppressing both the acute (phase 1: ED50, 14 ng/hr) and tonic (phase 2: ED50, 0.82 ng/hr) phases of the formalin test when it was infused for 72 hr immediately before testing. Phase 2 nociceptive responses were suppressed by bolus injections of 100 ng SNX- 111. SNX-111 was approximately 1000-fold more potent than morphine in blocking phase 2 responses when the compounds were administered by intrathecal bolus injection. In rats with an experimentally induced painful peripheral neuropathy, intrathecal bolus injections of 30 to 300 ng SNX-111 blocked mechanical allodynia in a dose-dependent manner. Subacute administration of SNX-111 (1, 10 and 100 ng/hr) by continuous intrathecal infusion produced a reversible blockade of mechanical allodynia without apparent development of tolerance. These results show that: 1) selective N-type VSCC blockers are potent and efficacious antinociceptive agents when they are administered by the spinal route; 2) selective N-type VSCC blockers are effective in rat models of acute, persistent and neuropathic pain; and 3) N-type VSCCs play a significant role in the spinal processing of noxious somatosensory input.

Volume 279, Issue 3, pp. 1243-1249, 12/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				C. Altier, C. S. Dale, A. E. Kisilevsky, K. Chapman, A. J. Castiglioni, E. A. Matthews, R. M. Evans, A. H. Dickenson, D. Lipscombe, N. Vergnolle, et al. Differential Role of N-Type Calcium Channel Splice Isoforms in Pain J. Neurosci., June 13, 2007; 27(24): 6363 - 6373. [Abstract] [Full Text] [PDF]

				B. K. Rycroft, K. S. Vikman, and M. J. Christie Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn J. Physiol., May 1, 2007; 580(3): 883 - 894. [Abstract] [Full Text] [PDF]

				A. J. Castiglioni, J. Raingo, and D. Lipscombe Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels J. Physiol., October 1, 2006; 576(1): 119 - 134. [Abstract] [Full Text] [PDF]

				E. E. Prommer Ziconotide: Can we use it in palliative care? American Journal of Hospice and Palliative Medicine, September 1, 2005; 22(5): 369 - 374. [Abstract] [PDF]

				P. S. Staats, T. Yearwood, S. G. Charapata, R. W. Presley, M. S. Wallace, M. Byas-Smith, R. Fisher, D. A. Bryce, E. A. Mangieri, R. R. Luther, et al. Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS: A Randomized Controlled Trial JAMA, January 7, 2004; 291(1): 63 - 70. [Abstract] [Full Text] [PDF]

				D. Wermeling, M. Drass, D. Ellis, M. Mayo, D. McGuire, D. O'Connell, V. Hale, and S. Chao Pharmacokinetics and Pharmacodynamics of Intrathecal Ziconotide in Chronic Pain Patients J. Clin. Pharmacol., June 1, 2003; 43(6): 624 - 636. [Abstract] [Full Text] [PDF]

				J. Sawynok Topical and Peripherally Acting Analgesics Pharmacol. Rev., March 1, 2003; 55(1): 1 - 20. [Abstract] [Full Text] [PDF]

				G. L. Kamatchi, M. E. Durieux, and C. Lynch III Differential Sensitivity of Expressed L-Type Calcium Channels and Muscarinic M1 Receptors to Volatile Anesthetics in Xenopus Oocytes J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 981 - 990. [Abstract] [Full Text]

				G. L. Kamatchi, S. N. Tiwari, M. E. Durieux, and C. Lynch III Effects of Volatile Anesthetics on the Direct and Indirect Protein Kinase C-Mediated Enhancement of alpha 1E-Type Ca2+ Current in Xenopus Oocytes J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 360 - 369. [Abstract] [Full Text]

				K. A. Sluka Blockade of N- and P/Q-Type Calcium Channels Reduces the Secondary Heat Hyperalgesia Induced by Acute Inflammation J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 232 - 237. [Abstract] [Full Text]